spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase PDB id
1icf
Jmol
Contents
Protein chains
175 a.a. *
42 a.a. *
65 a.a. *
Ligands
NAG ×2
Waters ×668
* Residue conservation analysis
PDB id:
1icf
Name: Hydrolase
Title: Crystal structure of mhc class ii associated p41 ii fragment complex with cathepsin l
Structure: Protein (cathepsin l: heavy chain). Chain: a, c. Protein (cathepsin l: light chain). Chain: b, d. Protein (invariant chain). Chain: i, j. Fragment: thyroglobulin type-1 domain. Synonym: ii fragment, cd74 fragment
Source: Homo sapiens. Human. Organism_taxid: 9606. Organ: kidney. Organ: kidney
Biol. unit: Trimer (from PQS)
Resolution:
2.00Å     R-factor:   0.182     R-free:   0.213
Authors: G.Guncar,G.Pungercic,I.Klemencic,V.Turk,D.Turk
Key ref:
G.Guncar et al. (1999). Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. Embo J, 18, 793-803. PubMed id: 10022822 DOI: 10.1093/emboj/18.4.793
Date:
07-Jan-99     Release date:   12-Jan-00    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P07711  (CATL1_HUMAN) -  Cathepsin L1
Seq:
Struc:
333 a.a.
175 a.a.
Protein chains
Pfam   ArchSchema ?
P07711  (CATL1_HUMAN) -  Cathepsin L1
Seq:
Struc:
333 a.a.
42 a.a.
Protein chains
Pfam   ArchSchema ?
P04233  (HG2A_HUMAN) -  HLA class II histocompatibility antigen gamma chain
Seq:
Struc:
296 a.a.
65 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chains A, B, C, D: E.C.3.4.22.15  - Cathepsin L.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specificity close to that of papain. As compared to cathepsin B, cathepsin L exhibits higher activity towards protein substrates, but has little activity on Z-Arg-Arg-NHMec, and no peptidyl-dipeptidase activity.
 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     proteolysis   1 term 
  Biochemical function     cysteine-type peptidase activity     2 terms  

 

 
DOI no: 10.1093/emboj/18.4.793 Embo J 18:793-803 (1999)
PubMed id: 10022822  
 
 
Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
G.Guncar, G.Pungercic, I.Klemencic, V.Turk, D.Turk.
 
  ABSTRACT  
 
The lysosomal cysteine proteases cathepsins S and L play crucial roles in the degradation of the invariant chain during maturation of MHC class II molecules and antigen processing. The p41 form of the invariant chain includes a fragment which specifically inhibits cathepsin L but not S. The crystal structure of the p41 fragment, a homologue of the thyroglobulin type-1 domains, has been determined at 2.0 A resolution in complex with cathepsin L. The structure of the p41 fragment demonstrates a novel fold, consisting of two subdomains, each stabilized by disulfide bridges. The first subdomain is an alpha-helix-beta-strand arrangement, whereas the second subdomain has a predominantly beta-strand arrangement. The wedge shape and three-loop arrangement of the p41 fragment bound to the active site cleft of cathepsin L are reminiscent of the inhibitory edge of cystatins, thus demonstrating the first example of convergent evolution observed in cysteine protease inhibitors. However, the different fold of the p41 fragment results in additional contacts with the top of the R-domain of the enzymes, which defines the specificity-determining S2 and S1' substrate-binding sites. This enables inhibitors based on the thyroglobulin type-1 domain fold, in contrast to the rather non-selective cystatins, to exhibit specificity for their target enzymes.
 
  Selected figure(s)  
 
Figure 2.
Figure 2 Schematic representation of the p41 fragment fold and its contacts with cathepsin L. p41 fragment residues are represented as circles, and interacting cathepsin L residues as squares. Dark grey shaded circles represent the C–CWC–C building element. Disulfide bridges are represented as dashed winding lines, hydrogen bonds and electrostatic interactions as dashed lines, and hydrophobic interactions as thin dotted lines. The Asn240F residue was observed in the electron density map to be glycosylated and is represented by a triangle.
Figure 7.
Figure 7 Structural role of the CWC sequence motif. The CWC sequence forms the core of the interface between the subdomains of the p41 fragment (thick lines) and of the superimposed fibrin-binding finger domain of tissue-type plasminogen activator (thin lines) (Downing et al., 1992). The figure was prepared with the program MAIN (Turk, 1992).
 
  The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: Embo J (1999, 18, 793-803) copyright 1999.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference Google scholar

  PubMed id Reference
19846555 M.Renko, J.Sabotic, M.Mihelic, J.Brzin, J.Kos, and D.Turk (2010).
Versatile loops in mycocypins inhibit three protease families.
  J Biol Chem, 285, 308-316.
PDB codes: 3h6q 3h6r 3h6s
20860624 M.Renko, U.Požgan, D.Majera, and D.Turk (2010).
Stefin A displaces the occluding loop of cathepsin B only by as much as required to bind to the active site cleft.
  FEBS J, 277, 4338-4345.  
20180650 V.Stoka, and V.Turk (2010).
A structural network associated with the kallikrein-kinin and renin-angiotensin systems.
  Biol Chem, 391, 443-454.  
18362148 M.Mihelic, A.Dobersek, G.Guncar, and D.Turk (2008).
Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
  J Biol Chem, 283, 14453-14460.  
17976004 M.Mihelic, and D.Turk (2007).
Two decades of thyroglobulin type-1 domain research.
  Biol Chem, 388, 1123-1130.  
16998715 S.Q.Wang, Q.S.Du, K.Zhao, A.X.Li, D.Q.Wei, and K.C.Chou (2007).
Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.
  Amino Acids, 33, 129-135.  
17502099 S.X.Wang, K.C.Pandey, J.Scharfstein, J.Whisstock, R.K.Huang, J.Jacobelli, R.J.Fletterick, P.J.Rosenthal, M.Abrahamson, L.S.Brinen, A.Rossi, A.Sali, and J.H.McKerrow (2007).
The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family.
  Structure, 15, 535-543.
PDB code: 2oul
17976006 T.Zavasnik-Bergant, and B.Turk (2007).
Cysteine proteases: destruction ability versus immunomodulation capacity in immune cells.
  Biol Chem, 388, 1141-1149.  
16407198 B.O.Smith, N.C.Picken, G.D.Westrop, K.Bromek, J.C.Mottram, and G.H.Coombs (2006).
The structure of Leishmania mexicana ICP provides evidence for convergent evolution of cysteine peptidase inhibitors.
  J Biol Chem, 281, 5821-5828.
PDB code: 2c34
16412578 C.Tardy, P.Codogno, H.Autefage, T.Levade, and N.Andrieu-Abadie (2006).
Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle).
  Biochim Biophys Acta, 1765, 101-125.  
17223738 N.Obermajer, B.Doljak, and J.Kos (2006).
Cysteine cathepsins: regulators of antitumour immune response.
  Expert Opin Biol Ther, 6, 1295-1309.  
16671941 T.Zavasnik-Bergant, and B.Turk (2006).
Cysteine cathepsins in the immune response.
  Tissue Antigens, 67, 349-355.  
15972819 A.Sala, S.Capaldi, M.Campagnoli, B.Faggion, S.Labò, M.Perduca, A.Romano, M.E.Carrizo, M.Valli, L.Visai, L.Minchiotti, M.Galliano, and H.L.Monaco (2005).
Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid.
  J Biol Chem, 280, 29812-29819.
PDB codes: 1zt3 1zt5
15775973 J.Otlewski, F.Jelen, M.Zakrzewska, and A.Oleksy (2005).
The many faces of protease-protein inhibitor interaction.
  EMBO J, 24, 1303-1310.  
16279937 J.T.Christeller (2005).
Evolutionary mechanisms acting on proteinase inhibitor variability.
  FEBS J, 272, 5710-5722.  
16181340 L.C.Hsing, and A.Y.Rudensky (2005).
The lysosomal cysteine proteases in MHC class II antigen presentation.
  Immunol Rev, 207, 229-241.  
16307485 L.Puzer, S.S.Cotrin, M.H.Cezari, I.Y.Hirata, M.A.Juliano, I.Stefe, D.Turk, B.Turk, L.Juliano, and A.K.Carmona (2005).
Recombinant human cathepsin X is a carboxymonopeptidase only: a comparison with cathepsins B and L.
  Biol Chem, 386, 1191-1195.  
15843150 P.Meh, M.Pavsic, V.Turk, A.Baici, and B.Lenarcic (2005).
Dual concentration-dependent activity of thyroglobulin type-1 domain of testican: specific inhibitor and substrate of cathepsin L.
  Biol Chem, 386, 75-83.  
16045611 T.F.Kagawa, P.W.O'toole, and J.C.Cooney (2005).
SpeB-Spi: a novel protease-inhibitor pair from Streptococcus pyogenes.
  Mol Microbiol, 57, 650-666.  
15195995 A.Rossi, Q.Deveraux, B.Turk, and A.Sali (2004).
Comprehensive search for cysteine cathepsins in the human genome.
  Biol Chem, 385, 363-372.  
15224094 C.Watts (2004).
The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
  Nat Immunol, 5, 685-692.  
14695297 G.Croce, A.Frache, M.Milanesio, L.Marchese, M.Causà, D.Viterbo, A.Barbaglia, V.Bolis, G.Bavestrello, C.Cerrano, U.Benatti, M.Pozzolini, M.Giovine, and H.Amenitsch (2004).
Structural characterization of siliceous spicules from marine sponges.
  Biophys J, 86, 526-534.  
15255182 M.Fonovic, D.Brömme, V.Turk, and B.Turk (2004).
Human cathepsin F: expression in baculovirus system, characterization and inhibition by protein inhibitors.
  Biol Chem, 385, 505-509.  
12887049 B.Turk, H.Fritz, and V.Turk (2003).
Vito Turk--30 years of research on cysteine proteases and their inhibitors.
  Biol Chem, 384, 833-836.  
12538657 C.Beers, K.Honey, S.Fink, K.Forbush, and A.Rudensky (2003).
Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
  J Exp Med, 197, 169-179.  
12554931 D.Turk, and G.Guncar (2003).
Lysosomal cysteine proteases (cathepsins): promising drug targets.
  Acta Crystallogr D Biol Crystallogr, 59, 203-213.  
14511383 J.P.Bocock, C.J.Edgell, H.S.Marr, and A.H.Erickson (2003).
Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L.
  Eur J Biochem, 270, 4008-4015.  
12776207 K.Honey, and A.Y.Rudensky (2003).
Lysosomal cysteine proteases regulate antigen presentation.
  Nat Rev Immunol, 3, 472-482.  
12833545 M.Sulpizi, A.Laio, J.VandeVondele, A.Cattaneo, U.Rothlisberger, and P.Carloni (2003).
Reaction mechanism of caspases: insights from QM/MM Car-Parrinello simulations.
  Proteins, 52, 212-224.  
12668429 M.Sulpizi, U.Rothlisberger, and P.Carloni (2003).
Molecular dynamics studies of caspase-3.
  Biophys J, 84, 2207-2215.  
11790528 A.M.Lennon-Duménil, A.H.Bakker, P.Wolf-Bryant, H.L.Ploegh, and C.Lagaudrière-Gesbert (2002).
A closer look at proteolysis and MHC-class-II-restricted antigen presentation.
  Curr Opin Immunol, 14, 15-21.  
12130637 C.Vannahme, N.Smyth, N.Miosge, S.Gösling, C.Frie, M.Paulsson, P.Maurer, and U.Hartmann (2002).
Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes.
  J Biol Chem, 277, 37977-37986.  
  12401493 D.C.Greenbaum, W.D.Arnold, F.Lu, L.Hayrapetian, A.Baruch, J.Krumrine, S.Toba, K.Chehade, D.Brömme, I.D.Kuntz, and M.Bogyo (2002).
Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design.
  Chem Biol, 9, 1085-1094.  
12142451 D.J.Rigden, V.V.Mosolov, and M.Y.Galperin (2002).
Sequence conservation in the chagasin family suggests a common trend in cysteine proteinase binding by unrelated protein inhibitors.
  Protein Sci, 11, 1971-1977.  
12417635 E.Fiebiger, R.Maehr, J.Villadangos, E.Weber, A.Erickson, E.Bikoff, H.L.Ploegh, and A.M.Lennon-Duménil (2002).
Invariant chain controls the activity of extracellular cathepsin L.
  J Exp Med, 196, 1263-1269.  
12530546 G.Pungercic, I.Dolenc, M.Dolinar, T.Bevec, S.Jenko, S.Kolaric, and V.Turk (2002).
Individual recombinant thyroglobulin type-1 domains are substrates for lysosomal cysteine proteinases.
  Biol Chem, 383, 1809-1812.  
11856830 J.P.Turkenburg, M.B.Lamers, A.M.Brzozowski, L.M.Wright, R.E.Hubbard, S.L.Sturt, and D.H.Williams (2002).
Structure of a Cys25-->Ser mutant of human cathepsin S.
  Acta Crystallogr D Biol Crystallogr, 58, 451-455.
PDB code: 1glo
11483509 A.M.Lennon-Duménil, R.A.Roberts, K.Valentijn, C.Driessen, H.S.Overkleeft, A.Erickson, P.J.Peters, E.Bikoff, H.L.Ploegh, and P.Wolf Bryant (2001).
The p41 isoform of invariant chain is a chaperone for cathepsin L.
  EMBO J, 20, 4055-4064.  
11154913 C.Watts (2001).
Antigen processing in the endocytic compartment.
  Curr Opin Immunol, 13, 26-31.  
11710834 J.Kos, A.Sekirnik, G.Kopitar, N.Cimerman, K.Kayser, A.Stremmer, W.Fiehn, and B.Werle (2001).
Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis.
  Br J Cancer, 85, 1193-1200.  
11517924 K.Brix, M.Linke, C.Tepel, and V.Herzog (2001).
Cysteine proteinases mediate extracellular prohormone processing in the thyroid.
  Biol Chem, 382, 717-725.  
11517943 N.Kopitar-Jerala, T.Bevec, D.Barlic-Maganja, F.Gubensek, and V.Turk (2001).
Anti-cathepsin L monoclonal antibodies that distinguish cathepsin L from cathepsin V.
  Biol Chem, 382, 867-870.  
11532926 V.Turk, B.Turk, and D.Turk (2001).
Lysosomal cysteine proteases: facts and opportunities.
  EMBO J, 20, 4629-4633.  
11517933 V.Zavasnik-Bergant, A.Sekirnik, R.Golouh, V.Turk, and J.Kos (2001).
Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue.
  Biol Chem, 382, 799-804.  
  10745011 G.Guncar, I.Klemencic, B.Turk, V.Turk, A.Karaoglanovic-Carmona, L.Juliano, and D.Turk (2000).
Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease.
  Structure, 8, 305-313.
PDB code: 1ef7
10722055 K.Galesa, B.Strukelj, S.Bavec, V.Turk, and B.Lenarcic (2000).
Cloning and expression of functional equistatin.
  Biol Chem, 381, 85-88.  
10679402 R.Busch, R.C.Doebele, N.S.Patil, A.Pashine, and E.D.Mellins (2000).
Accessory molecules for MHC class II peptide loading.
  Curr Opin Immunol, 12, 99.  
10679409 R.J.Riese, and H.A.Chapman (2000).
Cathepsins and compartmentalization in antigen presentation.
  Curr Opin Immunol, 12, 107-113.  
  11152132 S.Estrada, S.T.Olson, E.Raub-Segall, and I.Björk (2000).
The N-terminal region of cystatin A (stefin A) binds to papain subsequent to the two hairpin loops of the inhibitor. Demonstration of two-step binding by rapid-kinetic studies of cystatin A labeled at the N-terminus with a fluorescent reporter group.
  Protein Sci, 9, 2218-2224.  
10631947 R.Wubbolts, and J.Neefjes (1999).
Intracellular transport and peptide loading of MHC class II molecules: regulation by chaperones and motors.
  Immunol Rev, 172, 189-208.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.